6618 — JD Health International Share News
0.000.00%
- HK$123.02bn
- HK$66.26bn
- CNY73.44bn
Brief: JD Health International Announces Launch Of RMB Counter
Trip.com's Hong Kong shares rise on joining benchmark Hang Seng Index
Brief: Jd Health International Submits Application For Addition Of RMB Counter
Brief: Constituents Of Hang Seng Index To Increase To 80
Brief: Jd Health International Says Qtrly Revenue RMB13,950 Mln
Brief: JD Health International Says Dong Cao Resigned As CFO
Brief: JD.Com Founder's Long Position In Ordinary Shares Of JD Health Falls To 68.70% - HKEX Filing
JD takes China tech spinoffs to awkward new level
Brief: JD's Property Unit Files Listing Application To Hong Kong Stock Exchange - Filing
Brief: JD's Jingdong Industrials Files Listing Application To Hong Kong Stock Exchange
Brief: JD Health International Reports FY Non-IFRS Profit RMB2.62 Billion
In China, no easy way to get Pfizer's COVID drug Paxlovid (updated)
In China, no easy way to get Pfizer's COVID drug Paxlovid
Chinese rush to stock up antigen kits, medicines as COVID prevention curbs ease
Brief: Jd Health International - QTRLY Revenue Rmb10.52 Billion Versus Rmb7.40 Billion
Tencent, Alibaba rebound after sell-off; tech index rises
Brief: Jd Health International Bought Back 215,600 Shares For Hk$9.5 Million On Oct 20 - HKEX Filing
Brief: JD Health International Bought Back 618,350 Shares For HK$27.7 Mln On Oct 19 - HKEX Filing
Brief: JD Health International Bought Back 84,750 Shares For HK$3.8 Mln - HKEX Filing